Supplementary file 4_Global burden of pancreatitis among individuals aged 15–39 years: a systematic analysis from the 2021 GBD study.docx by Biwu Xu (21431858)

“…Gender-specific analysis revealed that females had lower prevalence and incidence rates compared to males. …”

Supplementary file 2_Global burden of pancreatitis among individuals aged 15–39 years: a systematic analysis from the 2021 GBD study.docx by Biwu Xu (21431858)

“…Gender-specific analysis revealed that females had lower prevalence and incidence rates compared to males. …”

Supplementary file 8_Global burden of pancreatitis among individuals aged 15–39 years: a systematic analysis from the 2021 GBD study.docx by Biwu Xu (21431858)

“…Gender-specific analysis revealed that females had lower prevalence and incidence rates compared to males. …”

Supplementary file 7_Global burden of pancreatitis among individuals aged 15–39 years: a systematic analysis from the 2021 GBD study.docx by Biwu Xu (21431858)

“…Gender-specific analysis revealed that females had lower prevalence and incidence rates compared to males. …”

Supplementary file 6_Global burden of pancreatitis among individuals aged 15–39 years: a systematic analysis from the 2021 GBD study.docx by Biwu Xu (21431858)

“…Gender-specific analysis revealed that females had lower prevalence and incidence rates compared to males. …”

Table 5_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

“…Post-PSM analysis revealed significantly lower 28-day all-cause mortality in the statin group (14.3% [870/6070]) compared to the no statin group (23.4% [1421/6070]). …”

Table 1_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

“…Post-PSM analysis revealed significantly lower 28-day all-cause mortality in the statin group (14.3% [870/6070]) compared to the no statin group (23.4% [1421/6070]). …”

Table 3_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

“…Post-PSM analysis revealed significantly lower 28-day all-cause mortality in the statin group (14.3% [870/6070]) compared to the no statin group (23.4% [1421/6070]). …”

Table 4_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

“…Post-PSM analysis revealed significantly lower 28-day all-cause mortality in the statin group (14.3% [870/6070]) compared to the no statin group (23.4% [1421/6070]). …”

Table 2_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

“…Post-PSM analysis revealed significantly lower 28-day all-cause mortality in the statin group (14.3% [870/6070]) compared to the no statin group (23.4% [1421/6070]). …”

Image 2_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

“…Post-PSM analysis revealed significantly lower 28-day all-cause mortality in the statin group (14.3% [870/6070]) compared to the no statin group (23.4% [1421/6070]). …”

Image 3_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

“…Post-PSM analysis revealed significantly lower 28-day all-cause mortality in the statin group (14.3% [870/6070]) compared to the no statin group (23.4% [1421/6070]). …”

Image 1_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

“…Post-PSM analysis revealed significantly lower 28-day all-cause mortality in the statin group (14.3% [870/6070]) compared to the no statin group (23.4% [1421/6070]). …”

Analysis of biases in amplicon coverage across samples sequenced with diverse Ampliseq-based protocols (DDD/IDI/III – corresponds to variations of PCR mix1 (I/D), ligase/buffer (I/... by P.A. Shatalov (21485215)

“…Coverage of amplicons by amplicon GC content analysis in samples sequenced on MGI platform (B) demonstrates extremely high amplitude between coverage of GC-low (30% and lower) and GC-moderate (40% and over) amplicons, while GC-high (70% and higher) amplicons demonstrate only slight decrease in coverage.…”

Image 7_Species-level taxonomic characterization of gut microbiota in HIV-infected individuals.pdf by Jiali Chen (5696)

“…ET-E was a unique enterotype in the PWH group, in which the abundance of Enterobacter was significantly increased. The absolute number of CD4⁺T lymphocytes and CD4/CD8 ratio were lower in ET-E HIV-infected individuals compared to those in the other two enterotypes. …”

Image 3_Species-level taxonomic characterization of gut microbiota in HIV-infected individuals.pdf by Jiali Chen (5696)

“…ET-E was a unique enterotype in the PWH group, in which the abundance of Enterobacter was significantly increased. The absolute number of CD4⁺T lymphocytes and CD4/CD8 ratio were lower in ET-E HIV-infected individuals compared to those in the other two enterotypes. …”

Table 1_Species-level taxonomic characterization of gut microbiota in HIV-infected individuals.xlsx by Jiali Chen (5696)

“…ET-E was a unique enterotype in the PWH group, in which the abundance of Enterobacter was significantly increased. The absolute number of CD4⁺T lymphocytes and CD4/CD8 ratio were lower in ET-E HIV-infected individuals compared to those in the other two enterotypes. …”

Image 4_Species-level taxonomic characterization of gut microbiota in HIV-infected individuals.pdf by Jiali Chen (5696)

“…ET-E was a unique enterotype in the PWH group, in which the abundance of Enterobacter was significantly increased. The absolute number of CD4⁺T lymphocytes and CD4/CD8 ratio were lower in ET-E HIV-infected individuals compared to those in the other two enterotypes. …”

Image 2_Species-level taxonomic characterization of gut microbiota in HIV-infected individuals.pdf by Jiali Chen (5696)

“…ET-E was a unique enterotype in the PWH group, in which the abundance of Enterobacter was significantly increased. The absolute number of CD4⁺T lymphocytes and CD4/CD8 ratio were lower in ET-E HIV-infected individuals compared to those in the other two enterotypes. …”

Image 1_Species-level taxonomic characterization of gut microbiota in HIV-infected individuals.pdf by Jiali Chen (5696)

“…ET-E was a unique enterotype in the PWH group, in which the abundance of Enterobacter was significantly increased. The absolute number of CD4⁺T lymphocytes and CD4/CD8 ratio were lower in ET-E HIV-infected individuals compared to those in the other two enterotypes. …”